Outlook Therapeutics
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OTLK and other ETFs, options, and stocks.About OTLK
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF.
CEOC. Russell Trenary
CEOC. Russell Trenary
Employees17
Employees17
HeadquartersIselin, New Jersey
HeadquartersIselin, New Jersey
Founded2010
Founded2010
Employees17
Employees17
OTLK Key Statistics
Market cap297.73M
Market cap297.73M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume731.84K
Average volume731.84K
High today$1.17
High today$1.17
Low today$1.11
Low today$1.11
Open price$1.13
Open price$1.13
Volume471.39K
Volume471.39K
52 Week high$2.12
52 Week high$2.12
52 Week low$0.6839
52 Week low$0.6839
OTLK Earnings
-$0.09
-$0.06
-$0.03
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Estimated-$0.04 per share
Estimated-$0.04 per share
ActualExpected Feb 14, Pre-Market
ActualExpected Feb 14, Pre-Market